HumanKine® recombinant proteins are created in HEK293 cells using animal free components
Proteins co-expressed in bacteria will not possess post- translational modifications, e.g., phosphorylation or glycosylation. For activity, many proteins require glycosylation and processing available exclusively in eukaryotic systems; specifically human systems for authentic human proteins.
All Humankine® recombinant proteins are produced in Proteintech’s in-house cGMP grade laboratory adhering to strict quality control regulations.
GMP Grade products available
To facilitate a seamless transition from pre-clinical to clinical studies, both Research Grade and GMP Grade HumanKine cytokines and growth factors are manufactured through the same production process, minimizing variability in performance between Research Grade and GMP Grade products.
Though Research Grade and GMP Grade products go through the same production process, GMP Grade products undergo a more rigorous quality check and there is more extensive documentation for traceability and transparency for regulatory requirements.
Authentic human proteins
Our human expression system ensures that proteins have native conformation and post-translational modifications to optimize biological activity. No expression tags, xeno-free…just high-quality proteins.
High purity, high activity Wnt3A without the high price
Wnt3A is critical for the regulation of cell fate and patterning during embryogenesis and plays a key role in maintaining the integrity of embryonic and adult tissues. Wnt3A recombinant proteins are an important component of stem cell and organoid cultures. The post-translational glycosylation and acylation of Wnts are essential for their efficient secretion and biological activity, which is why our HumanKine Wnt3A that is produced in HEK293 cells provides native human glycosylation for proper activity. HumanKine Wnt3A is twice as active as leading competitor’s product when compared side-by-side in two recognised, validated bio-assays.
Wnt3A recombinant protein is notoriously difficult to manufacture, with purity of most Wnt3A recombinant proteins on the market being in the range of 75%. However, Proteintech’s HumanKine recombinant cytokines and growth-factors have several
|Antibody||HumanKine®||Competitor A||Competitor B|
|Price/ 10µg||207€ / £199 / $399||636€ / £567 / $739||288€ / £214 / $399|
|Activity (EC50) (lower is better)||1.5 ng/mL||1.5-7.5 ng/mL||5-25 ng/mL|
Proteintech has developed a thermostable FGF (FGFbasic-TS), created in HEK293 cells using animal-free components
FGF is a required component of stem cell culture media for maintaining cells in an undifferentiated state. Because FGF is unstable, daily media changes are needed. Proteintech has developed a thermostable FGF basic (FGFbasic-TS) that supports a 2-day media change schedule, so no media changes are required over a weekend (Figure 1).
Basic fibroblast growth factor (FGFbasic), also known as bFGF, FGF2, FGF-β, or HBGF-2, belongs to the FGF family. FGF plays important roles in diverse biological functions in vivo and in vitro. It is involved in embryonic development, neuron differentiation, and the proliferation of cells of mesodermal origin and many cells of neuroectodermal, ectodermal, and endodermal origin.
Proteintech FGFbasic-TS HZ1285 maintains cell growth, pluripotency, and differentiation potential with a 2-day feeding schedule.
Independent research demonstrates HEK293 derived BMP-2 is more active and stable than either E. coli or CHO derived BMP-2
Bone morphogenetic protein-2 (BMP-2) can be isolated from bone or expressed recombinantly for use as a growth-factor to induce osteogenic differentiation of osteoblasts and their precursors. Experimentally, BMP-2 can be used in stem cell cultures to induce osteogenesis but is also the sole osteoinductive factor currently approved for clinical use by the FDA. Human BMP-2 is synthesized as a 396 amino acid (aa) preproprotein that contains a 23 aa signal sequence, a 259 aa pro-peptide, and a 114 aa mature region. Maturation of BMP-2 is a complex process that involves cleavage of pre-pro peptide; removal of signaling peptide; dimerization of the pro-peptide and proteolytic activation that enables mature BMP-2 to form active disulfide linked homodimer. Reduction of disulfide bonds result in loss of biological activity. It is known to increase alkaline phosphatase (ALP) expression through modulation of the Wnt signalling pathway; meaning ALP bio-assay detection can be used to calculate the bioactivity of recombinant human BMP-2.
Due to its importance in the stem cell research and clinical fields several companies are offering recombinant human BMP-2 for sale as a growth factor. Independent research conducted by Fung et al. in 2019 indicate that of the commercially available BMP-2 proteins tested, Proteintech’s HumanKine (previously named HumanZyme) HEK293 derived BMP-2 was the most active, and most stable product when compared with competitor BMP-2 derived from E. coli or CHO expression systems.
Figure 2 indicates that Proteintech’s HumanKine recombinant human BMP-2 (H1) leads to increased expression of ALP at the same concentration when compared to either international standard (Standard) or competitor BMP-2 derived from E. coli or CHO expression systems (above). This is confirmed by H1 having the lowest ED50 when compared to those same competitor products (right), and thus, the highest activity.
Figure 3 again demonstrates the superiority of the HumanKine BMP-2 as it has consistent stability (% concentration of Day 0) over the 700-hour time-course (C); whereas the competitor product’s % concentration of Day 0 declines rapidly throughout the same time course, indicating lower stability at 37°C (A)(B).
Proteintech HumanKine cytokines and growth factors are all HEK293 human cell derived. This means all HumanKine recombinant proteins are animal component free, xeno free and tag free, with native human glycosylation and folding, leading to increased activity and stability, as seen above. We are also proud to offer our HumanKine range as GMP grade (ISO 13485 certified).
Fung SL, Wu X, Maceren JP, Mao Y, Kohn J. In Vitro Evaluation of Recombinant Bone Morphogenetic Protein-2 Bioactivity for Regenerative Medicine. Tissue Eng Part C Methods. 2019 Sep;25(9):553-559. doi: 10. 1089/ten.TEC.2019.0156. PMID: 31418333; PMCID: PMC6761583.
Interleukin-2 (IL-2) is a cytokine secreted by T cells that signals through heterodimerization of the IL-2R‑ and IL-2Rβ subunits. It acts as a growth-factor for a wide range of leukocytes; inducing proliferation in CD4+ and CD8+ T cells, maintaining normal T regulatory cells function, and is essential in immune homeostasis and self-tolerance.
IL-2 can be used to stimulate cultured T cells, clonal expansion and proliferation of T cell populations, or to maintain normal function of cultured leukocytes such as NK cells and Tregs. It has also been used therapeutically in the treatment of numerous diseases, including cancer. The clinical benefit of IL-2 therapy comes from the expansion of T cell subsets that can target cancer cells in diseases such as renal cell carcinoma. IL-2 is also used in the production and differentiation of chimeric antigen receptor T cells for ground-breaking personalized CAR T cancer therapy.
Due to its importance both clinically and in research, many companies have produced and sold active recombinant human IL-2 protein. Figure 4 demonstrates that Proteintech’s HumanKine human cell expressed recombinant IL-2 is up to 40x more active than leading competitor IL-2 when benchmarked side-by-side in the competitor’s optimized assay protocol.
Please take a look at this concise overview of our research grade and GMP grade products and let us know if you are interested in any of our products. We will gladly provide more information.